Beximco Signs Contract With Mylan for Distribution in Bangladesh

Date : 02/24/2020 @ 9:38AM
Source : Dow Jones News
Stock : Roche Holdings Ltd AG (QX) (RHHBY)
Quote : 40.8  0.0 (0.00%) @ 2:15PM

Beximco Signs Contract With Mylan for Distribution in Bangladesh

Historical Stock Chart

2 Months : From Feb 2020 to Apr 2020

Click Here for more Roche (QX) Charts.

By Jaime Llinares Taboada


Beximco Pharmaceuticals Ltd. said Monday that it has signed a contract for distribution of certain products of Mylan NV in Bangladesh.

The London-listed company said it will receive the exclusive rights to launch Mylan's portfolio of monoclonal antibodies to treat different types of cancers, rheumatoid arthritis, Crohn's disease, ulcerative colitis and other medical conditions.

The first product to be launched, in the first quarter of 2020, will be Ogivri, a breast-cancer drug which is biosimilar to blockbuster drug Herceptin from Roche Holding AG, Beximco said.

Shares at 0900 GMT were up 1.8 pence, or 4.2%, at 45.0 pence.


Write to Jaime Llinares Taboada at; @JaimeLlinaresT


(END) Dow Jones Newswires

February 24, 2020 04:23 ET (09:23 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.